process · timing · cost
SAHPRA Section 21 in 2026 — typical timelines, costs, and what to expect
Last reviewed · Reviewed by Docto24 editorial
A practical, current snapshot of what a patient should expect from intake assessment to medication in hand. End-to-end timing, cost breakdown, and what affects each step.
Patients researching the SAHPRA Section 21 medical cannabis pathway often find conflicting information about how long it takes and what it actually costs. Some sources quote two-week turnaround; others quote weeks of delays. As of 2026, here is what a typical patient should reasonably expect.
End-to-end: 3–7 working days is normal
For a patient with a straightforward indication and complete documentation, the realistic timeline from intake assessment to medication in hand is **3 to 7 working days**. Outliers in either direction exist, but the typical experience falls inside that window.
**Day 0** — patient completes the intake assessment (≈5 minutes) and books a consultation. Async-text consultation is the standard option; video is available where the case warrants live conversation.
**Day 0–2** — doctor reviews the case and either accepts the assessment, requests a video upgrade, requests additional documentation, or declines. Most accepted cases are reviewed within 24–48 hours.
**Day 1–2** — for accepted cases, the Section 21 application is filed with SAHPRA the same day the case is approved.
**Day 2–5** — SAHPRA review. Typical turnaround is 2–3 working days for a complete and well-prepared application. Where SAHPRA requests additional information, the doctor responds within 24 hours wherever possible — that conversation can add 1–2 days.
**Day 4–7** — pharmacy dispense and courier delivery. Major SA metros (Cape Town, Johannesburg, Pretoria, Durban) usually receive within 1 working day of dispatch; outlying areas may add a day.
What can extend the timeline
**Incomplete first-line documentation** — applications that do not document a structured trial of conventional first-line therapy face delays or declines. The fix is supplying that documentation; the time cost depends on how quickly you can pull together specialist letters or medication histories.
**Specialist correspondence required** — some indications (epilepsy, MS, Parkinson's) routinely require specialist input on the application. If you do not have a recent letter, gathering one can add 1–4 weeks depending on the specialist's availability.
**Conditional SAHPRA approval** — SAHPRA can approve, request more information, or decline. A conditional decision typically means one round of doctor-SAHPRA correspondence (1–3 days), then approval.
**Public holidays** — SAHPRA review effectively pauses on SA public holidays. December–January and Easter periods are slower than average.
Cost breakdown
**Doctor consultation** — R500 for an HPCSA-registered doctor's clinical time, due whether the case is accepted or declined. The fee covers the assessment, clinical decision, and (where accepted) preparation of the SAHPRA application.
**SAHPRA Section 21 fee** — R400 per product. Statutory fee paid to SAHPRA, not to Docto24. If you are prescribed two products, you pay R400 × 2.
**Medication** — set by the dispensing pharmacy and visible before you confirm. Typical first-month cost varies widely (R600–R3000+) depending on indication, dose, and whether you have one product or several. The pharmacy is the price-setter; Docto24 does not mark up product.
**Delivery** — pharmacy-set, typically R50–R150 for major metros.
No subscription, no platform fee, no membership cost. Once your 6-month authorisation is approved, repeat dispenses within that window do not incur additional consultation or SAHPRA fees.
Glossary terms in this article
Researching whether the Section 21 cannabis pathway is right for you? The eligibility assessment takes around five minutes.
START ELIGIBILITY ASSESSMENT